(Q23919380)

2

0 references

Hongli Li

3

0 references

Eddie Reed

4

0 references

Fei Chen

Biochemical and Biophysical Research Communications

5

0 references

language of work or name

English

0 references

publication date

11 March 2005

0 references

published in

0 references

volume

328

0 references

issue

2

0 references

page(s)

567-572

0 references

on focus list of Wikimedia project

Wikimedia–NIOSH collaboration

0 references

cites work

Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

SCF and APC: the Yin and Yang of cell cycle regulated proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

Chk1 and Chk2 kinases in checkpoint control and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

Cyclin is degraded by the ubiquitin pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

CHK2 kinase--a busy messenger.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

Chk2 activates E2F-1 in response to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

Characterisation of molecular events following cisplatin treatment of two curable ovarian cancer models: contrasting role for p53 induction and apoptosis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

The anaphase-promoting complex: it's not just for mitosis any more.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

Activation of the ATM kinase by ionizing radiation and phosphorylation of p53

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

DNA damage-induced activation of p53 by the checkpoint kinase Chk2

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021

CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.01.007

7 January 2021